Clinical Trials in Pennsylvania

Showing 8261-8280 of 14,950 trials

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

NCT02903069

This study is for newly diagnosed WHO Grade IV malignant glioma patients to determine whether an investigational drug known as marizomib (MRZ) will improve the treatment of newly diagnosed glioblastoma patients by delaying the growth of the cancer, reducing the size of the tumor, and/or improving survival. Marizomib (MRZ) is being added to standard-of-care treatments of radiotherapy (RT), temozolomide (TMZ), and Optune.

GlioblastomaMalignant Glioma

Celgene66 participantsStarted Aug 2016

La Jolla, California, United States • Orange, California, United States • Santa Monica, California, United States +5 more locations

COMPLETEDNA36 miles

Standing Cognition and Co-morbidities of POTS Evaluation

NCT03602482

The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.

Postural Tachycardia SyndromeEhlers-Danlos Syndrome

Milton S. Hershey Medical Center139 participantsStarted Jun 2018

Hershey, Pennsylvania, United States

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Standing Cognition and Co-morbidities of POTS Evaluation

Find Trials by Condition in Pennsylvania

Autism Spectrum Ambassador Program (ASAP) in the ED

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Peer Led Asthma Self Management for Adolescents: PLASMA

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Rheos System for the Treatment of HFpEF Heart Failure

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

A Phase II Study of M2951 in SLE

UNITE Study: Understanding New Interventions With GBM ThErapy

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

The Tailored-Motivational Interviewing Project

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)